Millennium Management LLC Has $23.59 Million Stake in Acadia Healthcare Company, Inc. $ACHC

Millennium Management LLC lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 23.0% during the first quarter, according to its most recent filing with the SEC. The firm owned 777,934 shares of the company’s stock after selling 231,836 shares during the period. Millennium Management LLC owned 0.84% of Acadia Healthcare worth $23,587,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd lifted its position in shares of Acadia Healthcare by 11,218.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after acquiring an additional 1,234 shares during the period. UMB Bank n.a. lifted its position in shares of Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock valued at $38,000 after acquiring an additional 755 shares during the period. State of Wyoming acquired a new position in shares of Acadia Healthcare during the 4th quarter valued at $56,000. Covestor Ltd lifted its position in shares of Acadia Healthcare by 56.0% during the 1st quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after acquiring an additional 812 shares during the period. Finally, Twin Tree Management LP lifted its position in shares of Acadia Healthcare by 185.8% during the 1st quarter. Twin Tree Management LP now owns 5,691 shares of the company’s stock valued at $173,000 after acquiring an additional 3,700 shares during the period.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Mizuho dropped their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 13th. UBS Group dropped their target price on shares of Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Barclays dropped their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 7th. Stephens upgraded shares of Acadia Healthcare to a “hold” rating in a research note on Monday, June 2nd. Finally, Royal Bank Of Canada decreased their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $39.00.

Acadia Healthcare Price Performance

ACHC opened at $21.73 on Friday. The firm has a market cap of $2.01 billion, a P/E ratio of 14.39, a PEG ratio of 4.39 and a beta of 0.89. The firm has a 50-day moving average of $22.09 and a 200 day moving average of $24.29. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $79.82.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.